Related references
Note: Only part of the references are listed.Early Administration of Azathioprine vs Conventional Management of Crohn's Disease: A Randomized Controlled Trial
Jacques Cosnes et al.
GASTROENTEROLOGY (2013)
Early Azathioprine Therapy Is No More Effective Than Placebo for Newly Diagnosed Crohn's Disease
Julian Panes et al.
GASTROENTEROLOGY (2013)
Effect of intensive granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis positive for cytomegalovirus
Takumi Fukuchi et al.
JOURNAL OF CROHNS & COLITIS (2013)
Has There Been a Change in the Natural History of Crohn's Disease? Surgical Rates and Medical Management in a Population-Based Inception Cohort from Western Hungary Between 1977-2009
Peter Laszlo Lakatos et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Rapid induction of mucosal healing by intensive granulocyte and monocyte adsorptive aphaeresis in active ulcerative colitis patients without concomitant corticosteroid therapy
T. Fukuchi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Feasibility and safety of granulocytapheresis in Crohn's disease: A prospective cohort study
G. Bresci et al.
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE (2010)
Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease
Filip Baert et al.
GASTROENTEROLOGY (2010)
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease.
Jean Frederic Colombel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
An Open-Label Prospective Randomized Multicenter Study Shows Very Rapid Remission of Ulcerative Colitis by Intensive Granulocyte and Monocyte Adsorptive Apheresis as Compared With Routine Weekly Treatment
Atsushi Sakuraba et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
TNF alpha blockade in human diseases: An overview of efficacy and safety
Jan Lin et al.
CLINICAL IMMUNOLOGY (2008)
Risk factors for opportunistic infections in patients with inflammatory bowel disease
Murat Toruner et al.
GASTROENTEROLOGY (2008)
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease:: an open randomised trial
Geert D'Haens et al.
LANCET (2008)
Granulocyte, monocyte/macrophage apheresis for inflammatory bowel disease:: The first 100 patients treated in Scandinavia
Tryggve Ljung et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2007)
Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD
M Daperno et al.
GASTROINTESTINAL ENDOSCOPY (2004)
Clinical evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis
K Kanke et al.
DIGESTIVE AND LIVER DISEASE (2004)
Adsorptive granulocyte and monocyte apheresis for refractory Crohn's disease: an open multicenter prospective study
Y Fukuda et al.
JOURNAL OF GASTROENTEROLOGY (2004)
Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitis
H Hanai et al.
DIGESTION (2004)
Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes
AR Saniabadi et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2003)
Leukocyte Adsorptive Apheresis for the Treatment of Active Ulcerative Colitis: A Prospective, Uncontrolled, Pilot Study
Hiroyuki Hanai et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2003)
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study
WA Faubion et al.
GASTROENTEROLOGY (2001)
Share Paper
